Bilibili Likely To Gain From New Game Launches, Auto, 3C And Recovery In Performance Based Ads, Analysts Say
Citigroup analyst Brian Gong upgrades Bilibili Inc (NASDAQ: BILI) from
Small Cap Consumer Research Reiterates Buy on Betterware de Mexico SAPI, Maintains $15 Price Target
Small Cap Consumer Research analyst Eric Beder reiterates Betterware de Mexico SAPI (NASDAQ:BWMX) with a Buy and maintains $15 price target.
Barrington Research Reiterates Outperform on VIZIO Holding, Maintains $15 Price Target
Barrington Research analyst James Goss reiterates VIZIO Holding (NYSE:VZIO) with a Outperform and maintains $15 price target.
Needham Reiterates Buy on Cormedix, Maintains $13 Price Target
Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $13 price target.
Costco A Standout In Retail Sector For Analysts, But They Wonder Why No Membership Fee Hike
Retailer Costco Wholesale Corporation (NASDAQ: COST) reported second-quarter financial results after market close Thursday.
Burlington Best Suited To Benefit From Inventory Supply, Says Analyst
Telsey Advisory Group analyst Dana Telsey reiterated an Outperform rating on the shares of Burlington Stores (NYSE: BURL) with a price target of $250.
Benchmark Reiterates Buy on Bilibili, Maintains $35 Price Target
Benchmark reiterates Bilibili (NASDAQ:BILI) with a Buy and maintains $35 price target.
Why ChargePoint’s Dip Is Your Ticket To Electric Profits: What 2 Analysts Think
Shares of ChargePoint Holdings Inc (NYSE: CHPT) fell more than 11% in Friday’s premarket session after the company reported an earnings miss and issued guidance below consensus estimates.
EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target
EF Hutton analyst Constantine Davides reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $22.5 price target.
Chardan Capital Reiterates Buy on EyePoint Pharmaceuticals, Maintains $21 Price Target
Chardan Capital analyst Daniil Gataulin reiterates EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and maintains $21 price target.